SWFI First Read, February 28, 2018

Posted on 02/28/2018


Temasek Invests in Viela Bio Gaithersburg, Maryland-based Viela Bio has incorporated as an independent inflammation- and autoimmunity-focused biotechnology company after spinning out six molecules from MedImmune, the global biologics research and development arm of AstraZeneca. Viela Bio raised US$ 250 million from an investor group led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital, […]